Showing results (591-600 of 785) with videos related to

Sort By:
Pageof 79
Bone Research|December 10, 2020
Mechanical suppression of breast cancer cell invasion and paracrine signaling to osteoclasts requires nucleo-cytoskeletal connectivityXin Yi, Laura E Wright, Gabriel M Pagnotti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2020
Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal OutcomesJacob E Ollech, Irit Avni-Biron, Laura Glick, et al.
Gastroenterology|August 28, 2020
Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative ColitisKatherine Li, Colleen Marano, Hongyan Zhang, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
The New England Journal of Medicine|April 9, 1987
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 aloneS A Rosenberg, M T Lotze, L M Muul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapyS N Bock, R E Lee, B Fisher, et al.
Inflammatory Bowel Diseases|May 11, 2011
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenesJoel R Pekow, Urszula Dougherty, Reba Mustafi, et al.
Crohn'S & Colitis 360|February 13, 2023
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United StatesSimon J Hong, Noa Krugliak Cleveland, Shintaro Akiyama, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Pageof 79